The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Cardinal Health
Consulting or Advisory Role - Takeda
The significance of beta-II microglobulin (β2M) and International Staging System (ISS) in multiple myeloma (MM) patients (pts.) with renal impairment (RI).
 
Gloria Lin
No Relationships to Disclose
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Saurabh Chhabra
No Relationships to Disclose
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - ADC Therapeutics; Cellerant Therapeutics; Incyte; Janssen Research & Development; MedImmune; Pharmacyclics; Puma Biotechnology (I); Verastem
Speakers' Bureau - AstraZeneca; Celgene; Genzyme
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Anita D'Souza
Consulting or Advisory Role - Pfizer; Prothena
Research Funding - Merck (Inst); Mundipharma (Inst); Prothena (Inst); Sanofi (Inst)
 
Aniko Szabo
No Relationships to Disclose
 
Binod Dhakal
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Celgene
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen; Takeda
Research Funding - Amgen (Inst); Janssen (Inst)